-
The American Medical Association and many other professional organizations demand “peer-reviewed science” before they will recommend or even accept the re-purposing of a long-established anti-malaria drug to treat or prevent COVID-19.
-
Clinical trials do more than inform us whether a drug is effective. They inform us when a drug is effective, in what combinations, in what dosages, and what are the counter indications.
-
The word has leaked out on a potential cheap treatment for COVID-19, the antimalarial drug hydroxychloroquine.
